These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2459557)

  • 1. Hemodynamic effects of penticainide (CM 7857), a novel class I antiarrhythmic drug--comparison with disopyramide.
    Pfisterer M; Munoz A; Burkart F
    J Cardiovasc Pharmacol; 1988 Aug; 12(2):247-51. PubMed ID: 2459557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of three class I antiarrhythmic drugs on plateau and pacemaker currents of sheep cardiac Purkinje fibres.
    Coraboeuf E; Deroubaix E; Escande D; Coulombe A
    Cardiovasc Res; 1988 Jun; 22(6):375-84. PubMed ID: 2852055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiarrhythmic efficacy of penticainide and comparison with disopyramide, flecainide, propafenone and mexiletine by acute oral drug testing.
    Priori SG; Bonazzi O; Facchini M; Varisco T; Schwartz PJ
    Am J Cardiol; 1987 Nov; 60(13):1068-72. PubMed ID: 3118693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects and pharmacokinetics of intravenous penticainide (CM 7857).
    Aliot E; Munoz A; Khalife K; Necciari J; Gagnol JP; Gilgenkrantz JM
    Eur Heart J; 1987 Jun; 8(6):618-23. PubMed ID: 3622542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium.
    Gautier P; Guiraudou P; Pezziardi F; Bertrand JP; Gagnol JP
    J Cardiovasc Pharmacol; 1987 May; 9(5):601-10. PubMed ID: 2439843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiological effects of penticainide (CM 7857) in isolated human atrial and ventricular fibers.
    Gautier P; Escande D; Bertrand JP; Seguin J; Guiraudou P
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):328-35. PubMed ID: 2468966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade.
    Pugsley MK; Hayes ES; Saint DA; Walker MJA
    Biomed Pharmacother; 2019 Mar; 111():427-435. PubMed ID: 30594781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of penticainide in the anaesthetized dog.
    Sassine A; Brugada J; Munoz A; Romero-Ayala L; Masse C
    Drugs Exp Clin Res; 1987; 13(1):15-20. PubMed ID: 3595440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
    Thadani U; Manyari D; Gregor P; Olowoyeye J; Leach A; West RO; Parker JO
    Cathet Cardiovasc Diagn; 1981; 7(1):27-34. PubMed ID: 7214518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic and electrocardiographic effects of disopyramide in patients with ventricular arrhythmia.
    Hulting J; Rosenhamer G
    Acta Med Scand; 1976; 199(1-2):41-51. PubMed ID: 1251772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative studies on the cardiodepressant effect of disopyramide, mexiletine and propafenon].
    Angermann C; Jahrmärker H
    Z Kardiol; 1983 Nov; 72(11):665-74. PubMed ID: 6659643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of CM7857, a derivative of disopyramide, on electrophysiologic properties of canine Purkinje fibers and inotropic properties of canine ventricular muscle.
    Endou K; Yamamoto H; Sato T; Nakata F
    J Cardiovasc Pharmacol; 1986; 8(3):507-13. PubMed ID: 2425165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic and electrophysiological effects of amiodarone, lignocaine, and penticainide in anaesthetised rats.
    Li JY; Northover BJ
    Cardiovasc Res; 1992 Nov; 26(11):1116-20. PubMed ID: 1291090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic effects of combined application of class I antiarrhythmic drugs; addition of low-dose mexiletine-enhanced antiarrhythmic effects of disopyramide and aprindine in various-rate canine ventricular tachycardias.
    Awaji T; Hashimoto K
    J Cardiovasc Pharmacol; 1993 Jun; 21(6):960-6. PubMed ID: 7687723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of the block of single Na+ channels in guinea-pig ventricular myocytes by the local anaesthetic penticainide.
    Carmeliet E; Nilius B; Vereecke J
    J Physiol; 1989 Feb; 409():241-62. PubMed ID: 2555476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SC-36602, a new antiarrhythmic agent: comparison of its cardiovascular profile with that of other antiarrhythmic drugs.
    Frederick LG; Hatley FR; McDonald SJ; Stamm MH; Garthwaite SM
    J Cardiovasc Pharmacol; 1988 Jun; 11(6):657-66. PubMed ID: 2457760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic effect related to the plasma concentration of pentisomide in vivo and the antiarrhythmic-concentration relationship in vitro.
    Hachisu M; Chen H; Soneda T; Fujishima K; Ishizuka T; Konno F
    Drugs Exp Clin Res; 1995; 21(4):145-51. PubMed ID: 8529527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.